These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11477750)

  • 1. Rationale for combined hemoperfusion/hemodialysis in uremia.
    Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
    Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 3. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of sorbents in uremia.
    Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW
    Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746
    [No Abstract]   [Full Text] [Related]  

  • 5. Middle molecules as a marker of uremic toxins.
    Wu ZG; Liao LT; Cai ZH; Lu ZN; Cai YD; Sheng PF
    Adv Exp Med Biol; 1987; 223():33-7. PubMed ID: 3447449
    [No Abstract]   [Full Text] [Related]  

  • 6. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemosorption as a treatment method for uremic complications].
    Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
    Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
    [No Abstract]   [Full Text] [Related]  

  • 8. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle molecules re-examined.
    Henderson LW
    Nephron; 1978; 22(1-3):146-52. PubMed ID: 745634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new coated charcoal for hemoperfusion in uremia.
    Stefoni S; Feliciangeli G; Coli L; Bonomini V
    Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
    Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortened treatment time by combined hemodialysis and hemoperfusion.
    Bonomini V; Stefoni S; Feliciangeli G; Colì L; Scolari MP; Orsi C; Nanni Costa A; Prandini R; Galanti S
    Contrib Nephrol; 1985; 44():57-64. PubMed ID: 3987293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adsorbents in the treatment of uremia. Hemoperfusion plus hemodialysis].
    Stalteri A; Rapisarda LM; Battiati E; Galione A; Picone F; Falco M; Romano M
    Minerva Nefrol; 1979; 26(2):217-20. PubMed ID: 471354
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemoperfusion combined with hemodialysis filtration can effectively improve uremia complicated with bone and mineral disorders.
    Tang X; Wang J; Li H; Wang X; Feng X; Zhang A; Chen R; Wei K; Cong Y
    Panminerva Med; 2021 Sep; 63(3):394-395. PubMed ID: 31355611
    [No Abstract]   [Full Text] [Related]  

  • 15. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG; Danielson BG; Fellström B; Wikström B
    Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Removal of middle molecule peptides from the blood during hemodialysis].
    Bakaev VV; Khomenko VF
    Lab Delo; 1989; (1):64. PubMed ID: 2468036
    [No Abstract]   [Full Text] [Related]  

  • 17. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.
    Stefoni S; Colì L; Feliciangeli G; Scolari MP; Bonomini V
    Int J Artif Organs; 1986 Sep; 9(5):297-300. PubMed ID: 3781660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hemoperfusion/hemodialysis in the treatment of uremic patients with vascular access problems: case reports.
    Espinosa-Meléndez E; Bourgouin PA; Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):309-12. PubMed ID: 3781661
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of hemoperfusion as an adjunct to hemodialysis.
    Trafford A; Ireland R; Evans R
    Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.